Stokes Family Office’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,409
Closed -$132K 343
2023
Q3
$132K Buy
13,409
+1,303
+11% +$13.6K 0.02% 316
2023
Q2
$121K Buy
12,106
+596
+5% +$5.69K 0.01% 311
2023
Q1
$111K Buy
11,510
+1,380
+14% +$15.3K 0.01% 285
2022
Q4
$113K Buy
+10,130
New +$106K 0.01% 265
2022
Q1
Sell
-10,005
Closed -$135K 285
2021
Q4
$135K Sell
10,005
-161
-2% -$2.15K 0.02% 243
2021
Q3
$138K Sell
10,166
-776
-7% -$11K 0.02% 222
2021
Q2
$156K Sell
10,942
-411
-4% -$5.95K 0.02% 213
2021
Q1
$159K Sell
11,353
-660
-5% -$10.8K 0.02% 190
2020
Q4
$225K Buy
+12,013
New +$196K 0.04% 157

Other funds holding VTRS

Stokes Family Office's VTRS Position: Q4 2023 in Review

Stokes Family Office sold out of Viatris (VTRS) in Q4 2023, closing a stake of 13,409 shares — an estimated $132K sold.

Stokes Family Office first reported a position in VTRS in Q4 2020 and held it in 9 quarters. The position peaked at $225K in Q4 2020. 1,014 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Stokes Family Office reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Stokes Family Office sold 13,409 Viatris shares in Q4 2023, an estimated $132K.
  • Stokes Family Office first reported a position in Viatris in Q4 2020 and held it in 9 quarters.
  • Stokes Family Office's Viatris position peaked at $225K in Q4 2020.
  • 1,014 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Stokes Family Office's 13F filing for Q4 2023, filed 6 Feb 2024.